Published in Hepatitis Weekly, December 4th, 2000
Researchers with the U.S. National Institutes of Health and with the companies Novavax and Bioqual, both in Rockville, Maryland, reported their early study findings on this vaccine at the 49th annual meeting of the American Society of Tropical Medicine and Hygiene, held October 29 - November 2, 2000, in Houston, Texas.
According to background information in the presentation by M. Zhang et al. ("Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.